We are creating new treatment options by adding innovation to established FDA-approved treatments and developing novel compounds. By focusing on new drug delivery systems, across various indications, we aim to increase product compliance and maximize the ability to achieve full therapeutic efficacy.
Utilizing the latest medical advancements, our innovative molecular technologies are being developed to increase compliance and maximize the patient’s ability to achieve full therapeutic efficacy.
Transdermal and topical delivery systems will reinvent how patients and physicians worldwide manage pain. We are developing novel compounds and adding innovation to established FDA approved treatments with bioequivalent formulations and improved attributes.
Our first-in-class transdermal spray film technology with delivery molecules is being developed to manage acute pain and chronic pain. The non-opioid molecules are also effective in treating central nervous system and inflammatory diseases.
We are developing novel drug delivery systems and continuously seeking patents in various therapeutic areas.